Kirksville Missouri Hospital Company, LLC
Kirksville Missouri Hospital Company, LLC was paid $7.98M by Medicaid between Jan 2018 and Dec 2024, across 70 billing codes. Its largest line is X4011, State-specific procedure code — 19% of everything it billed.
KIRKSVILLE, MO 63501
Next to other General Acute Care Hospital providers in Missouri
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,568 | $2.27M | |
| 2019 | 9,594 | $1.80M | |
| 2020 | 6,904 | $638K | |
| 2021 | 12,053 | $361K | |
| 2022 | 15,181 | $841K | |
| 2023 | 17,241 | $1.02M | |
| 2024incomplete | 14,782 | $1.04M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X4011 | State-specific procedure code | 19% | 4,971 | 4,319 | $1.54M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 8,991 | 7,836 | $1.46M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 8,401 | 7,510 | $1.23M |
| 80053 | Comprehensive metabolic panel | 7.3% | 11,914 | 10,079 | $579K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.7% | 12,746 | 10,753 | $537K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.3% | 823 | 747 | $341K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 2,010 | 1,775 | $220K |
| 86140 | 2.6% | 2,990 | 2,496 | $207K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 4,831 | 3,802 | $206K |
| 83605 | 2.3% | 3,609 | 2,917 | $187K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.2% | 941 | 810 | $177K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.1% | 2,496 | 2,208 | $171K |
58 more codes
| 71045 | Radiologic examination, chest; single view | 1.7% | 2,556 | $136K |
| D7999 | 1.5% | 25 | $119K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 2,102 | $94K |
| X4006 | <1% | 91 | $77K | |
| 81003 | <1% | 1,521 | $62K | |
| 59025 | Fetal non-stress test | <1% | 393 | $62K |
| 88304 | <1% | 13 | $52K | |
| 81001 | <1% | 1,400 | $50K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 576 | $47K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,062 | $45K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,308 | $45K |
| 84484 | <1% | 2,360 | $44K | |
| 87632 | <1% | 279 | $40K | |
| 87040 | <1% | 239 | $31K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 128 | $24K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 76 | $19K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 261 | $18K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 91 | $13K |
| 84145 | <1% | 59 | $13K | |
| 83690 | <1% | 564 | $11K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 116 | $10K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 111 | $9K |
| 87430 | <1% | 15 | $9K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 119 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 587 | $7K |
| 83735 | <1% | 552 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 180 | $7K |
| 83874 | <1% | 87 | $6K | |
| 82553 | <1% | 88 | $6K | |
| 64483 | <1% | 14 | $6K | |
| 82150 | <1% | 61 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 15 | $6K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 250 | $3K |
| 85730 | <1% | 34 | $3K | |
| 85610 | <1% | 34 | $3K | |
| Y7506 | <1% | 269 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 14 | $2K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 27 | $2K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 23 | $2K |
| 80061 | Lipid panel | <1% | 170 | $2K |
| 93017 | <1% | 14 | $1K | |
| 83880 | <1% | 109 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 145 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 47 | $1K |
| 84703 | <1% | 225 | $940.97 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 86 | $318.56 |
| 81025 | <1% | 41 | $243.41 | |
| 99152 | <1% | 198 | $222.20 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 18 | $195.70 |
| 87186 | <1% | 32 | $174.40 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 75 | $159.55 |
| 87077 | <1% | 19 | $91.63 | |
| J3490 | Unclassified drugs | <1% | 651 | $22.35 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 494 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 14 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 240 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 200 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 122 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.